This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Encounter, Patient, Practitioner |
Oral Chemotherapy Order - Myleran - completed - with reasonCode
{ "resourceType": "MedicationRequest", "id": "medrx0306", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: medrx0306</p><p><b>contained</b>: </p><p><b>identifier</b>: 12345689 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: Myleran 2mg tablet. Generated Summary: id: med0304; Myleran 2mg tablet, film coated <span>(Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = '76388-713-25', given as 'Myleran 2mg tablet, film coated'})</span></p><p><b>subject</b>: <a>Donald Duck</a></p><p><b>authoredOn</b>: 15/01/2015</p><h3>Requesters</h3><table><tr><td>-</td><td><b>Agent</b></td><td><b>OnBehalfOf</b></td></tr><tr><td>*</td><td><a>Patrick Pump</a></td><td><a>Organization/f002</a></td></tr></table><p><b>reasonCode</b>: Chronic myeloid Leukemia (disorder) <span>(Details : {SNOMED CT code '92818009' = 'Chronic myeloid leukemia', given as 'Chronic myeloid Leukemia (disorder)'})</span></p><p><b>dosageInstruction</b>: </p></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0304", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "76388-713-25", "display": "Myleran 2mg tablet, film coated" } ] } } ], "identifier": [ { "use": "official", "system": "http://www.bmc.nl/portal/prescriptions", "value": "12345689" } ], "status": "active", "intent": "order", "medicationReference": { "reference": "#med0304", "display": "Myleran 2mg tablet" }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "authoredOn": "2015-01-15", "requester": { "agent": { "reference": "Practitioner/f007", "display": "Patrick Pump" }, "onBehalfOf": { "reference": "Organization/f002" } }, "reasonCode": [ { "coding": [ { "system": "http://snomed.info/sct", "code": "92818009", "display": "Chronic myeloid Leukemia (disorder)" } ] } ], "dosageInstruction": [ { "sequence": 1, "text": "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL", "timing": { "repeat": { "frequency": 1, "period": 1, "periodUnit": "d" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "26643006", "display": "Oral route (qualifier value)" } ] }, "doseQuantity": { "value": 6, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.